Compound ID | 3050
Class: Antimicrobial peptide
Spectrum of activity: | Gram-positive |
Details of activity: | Active against Staphylococcus aureus, Corynebacterium xerosis, Bacillus anthracis, and Streptococcus pneumoniae |
Propensity to select resistant mutants: | Yes, at 10^-5 mutation frequency at 35 ug/ml |
Description: | Natural product from Streptomyces albaduncus; shows curative dose (CD50) comparable to penicillin G in treating Staphylococcus aureus infection in mice; a sideromycin |
Institute where first reported: | Bristol-Banyu Research Institute, Ltd. |
Year first mentioned: | 1964 |
Highest developmental phase: | Preclinical |
Development status: | Experimental |